Makena Withdrawal Hearing: US FDA Drugs Center, Covis Tussle Over Panel Composition

 
• By Sue Sutter
Thumbs up thumbs down
CDER and Covis disagree on the expertise needed for the Makena public hearing panel and on disclosure issues. • Source: Alamy

More from Review Pathways

More from Pathways & Standards